| Code | 2367E | ||||||||||
| MA number | EU/1/22/1698/001 | ||||||||||
| Product Form: | tbl flm 28x14 mg (blis.Al/OPA/PVC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Mylan Pharmaceuticals Limited, Ireland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.11.2022 |
| Validity: | 09.11.2027 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Teriflunomid_Karta pre pacienta.pdf
|
| Dokument: |
Teriflunomid_Pokyny pre zdravotníckych pracovníkov.pdf
|
| Safety feature | Yes |
| Data update: | 24.11.2022 |
